Identifying cross-cultural variations in psychostimulant use for attention deficit hyperactivity disorder using
Manonita Ghosh1, C D'Arcy J Holman1, David B Preen1
1School of Population Health, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009 Australia.
Child and Adolescent Psychiatry and Mental Health
|March 24, 2017
Summary
Individuals from non-Anglophonic backgrounds were half as likely to receive stimulant medication for attention-deficit/hyperactivity disorder (ADHD). Cultural factors may influence ADHD treatment access and outcomes.
Area of Science:
- Neuroscience
- Psychiatry
- Public Health
Background:
- Disparities in stimulant use for attention-deficit/hyperactivity disorder (ADHD) exist.
- Country-of-birth is a potential factor influencing these disparities.
Purpose of the Study:
- To validate the association between country-of-birth and disparities in stimulant treatment for ADHD.
- To investigate the influence of geographical remoteness and socioeconomic status on ADHD stimulant prescription.
Main Methods:
- Population-based retrospective cohort study using linked data in Western Australia.
- Analysis of individuals admitted to hospital before age 25 between 2003-2007.
- Multivariate logistic and linear regressions to assess associations.
Main Results:
- 2.1% of 679,645 individuals received stimulants for ADHD.
- Individuals from non-Anglophonic backgrounds were half as likely to receive stimulants (OR = 0.53).
- Non-Anglophones were older at stimulant onset; disadvantaged and remote individuals received stimulants at younger ages.
Conclusions:
- Cultural differences significantly impact stimulant treatment for ADHD.
- Awareness of cultural variations is crucial for effective ADHD management.
- Fostering trust between patients and clinicians can improve ADHD treatment outcomes.
More Related Videos
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
11.1K
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
6.5K
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
1.1K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.0K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.0K
01:29Stimulants
1.1K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.1K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
765
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
765
01:22CNS Stimulants: Psychedelic Agents
913
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
913
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K